This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Industry-Academic Cooperation Foundation, Nal Pharmaceuticals, Ltd., Taho Pharmaceuticals Ltd.. Active years: 2015-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 21 
1 out of 8 
1 out of 11 Years Active: 2015-2020
Title: **Inventor Myung-kwan Chun: Pioneering Advances in Transdermal Drug Delivery Systems**
Introduction
Myung-kwan Chun is a notable inventor based in Seoul, South Korea, recognized for his contributions to the pharmaceutical industry. With a total of two patents, Chun has focused his innovative efforts on the development of transdermal drug delivery systems, which play a crucial role in providing effective and efficient medication administration.
Latest Patents
Chun's latest inventions include:
1. **Transdermal Delivery System Containing Galantamine or Salts Thereof**: This invention features a drug-containing matrix layer that utilizes galantamine or its pharmaceutically acceptable salt as the active ingredient, combined with a styrene-butadiene-styrene copolymer or a styrene-isoprene-styrene copolymer as an adhesive.
2. **Transdermal Drug Delivery System Containing Donepezil**: The second patent provides a transdermal drug delivery system incorporating donepezil or a pharmaceutically acceptable salt thereof as the active ingredient, along with an acrylate-rubber hybrid as an adhesive.
Career Highlights
Throughout his career, Myung-kwan Chun has worked with esteemed organizations such as the Industry-Academic Cooperation Foundation and Taho Pharmaceuticals Ltd. His experience in these organizations has propelled his research and development in the field of transdermal drug delivery systems, establishing him as a leading figure in his domain.
Collaborations
Chun has collaborated with several talented individuals in his career, including Hoo-kyun Choi and Y. Joseph Mo. These collaborations have enhanced his research efforts and contributed to advancing technology in the pharmaceutical sector.
Conclusion
Myung-kwan Chun's innovative patents in the realm of transdermal drug delivery systems reflect his commitment to improving drug administration methods. His work not only shows promise for better therapeutic outcomes but also underscores the importance of collaboration and innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile